MedPath

Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)

Phase 3
Terminated
Conditions
Femoral Neck Fractures
Interventions
Procedure: Sliding Hip Screw
Procedure: Cancellous Screws
Drug: Vitamin D Placebo
Registration Number
NCT01908751
Lead Sponsor
McMaster University
Brief Summary

The purpose of this study is to determine the impact of surgical fixation (cancellous screws versus sliding hip screws) and biologic intervention (Vitamin D versus placebo) on patient important outcomes.

Detailed Description

Femoral neck fractures are a type of hip fracture associated with high complication rates and poor functional outcomes. It is estimated that over 300,000 hip fractures occur in patients under age 50 annually. Hip fractures in younger aged patients are particularly devastating with profound impairments of quality of life and function. Virtually all patients require surgical repair of their fractures and unlike elderly hip fractures, failure of surgery offers few options for salvage. Arthroplasty is a successful treatment for elderly patients; however, a hip replacement is not a viable option for younger patients because of their higher functional demands for work and recreational activities that are not tolerated by joint replacements.

There is more than one way to perform internal fixation for femoral neck fractures. Cancellous screws have traditionally been the preferred internal fixation implant for femoral neck fractures. Multiple screws (2 or more) are used during fixation, and advocates of this implant promote the construct's superior torsional stability, limited disruption of femoral head blood supply, minimally invasive insertion, and retention of more viable bone than the larger sliding hip screw (SHS). On the other hand, sliding hip screws have been gaining popularity and there is evidence to suggest that SHS provide greater fracture stability and may reduce patient complications. It is currently unknown which method of internal fixation provides the best outcomes for patients.

Femoral neck fracture treatment is further complicated by vitamin D insufficiency in as many as 8 of 10 trauma patients. Vitamin D plays an important role in musculoskeletal health and bone quality because it regulates serum calcium homeostasis. Laboratory research and human clinical studies suggest important associations between vitamin D, musculoskeletal health, and improved fracture healing. Experimental animal studies have demonstrated the concentration of vitamin D metabolites are higher at a fracture callus compared to the uninjured contralateral bone, vitamin D supplementation leads to decreased time to fracture union and increased callus vascularity, and vitamin D increases mechanical bone strength compared to controls. Clinical studies have also demonstrated that vitamin D supplementation increases the callus volume of proximal humerus fractures, increases the number and diameter of type II muscle fibres, and can improve wound healing, however, the effects of vitamin D supplementation in you patients with femoral neck fractures are unknown.

Using a 2x2 factorial design, participant will be randomly allocated to one of four treatment arms. Participants allocated to the cancellous screw group will receive multiple threaded screws (with a minimum of 3 screws and a minimum diameter of 6.5 mm) and those allocated to the sliding hip screw group will receive a single larger diameter partially threaded screw affixed to the proximal femur with a sideplate using a minimum of 2 screws for fixation. Participants allocated to the vitamin D Group will receive a bottle of 2,000 International Units (IU) vitamin D3 drops. Participants will be instructed to take two drops daily for six months, for a total daily dose of 4,000 IU. Participants in the placebo group will receive an identical bottle of placebo drops with no active ingredient. Similarly, they will be instructed to take two drops daily for six months. All vitamin D3 supplement and placebo bottles will be labeled in a blinded manner according to Health Canada and Good Manufacturing Practice.

Participation in this study will last 12 months. In-person participant follow-up visits will occur at enrollment (baseline), post-surgery, 6 weeks, 3 months, 6 months, 9 months, and 12 months post-surgery. Data for all outcomes and radiographs will be collected at each follow-up visit.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
91
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Sliding Hip Screw and Vitamin D placeboSliding Hip ScrewParticipants in the placebo group will receive an identical bottle of placebo drops with no active ingredient. Similarly, they will be instructed to take two drops daily for six months. The placebo supplement is also manufactured by the Ddrops Company.
Cancellous Screws and Vitamin D supplementationCancellous ScrewsParticipants allocated to the vitamin D Group will be given a six-month supply of vitamin D3 supplementation. Participants in the vitamin D Group will receive a bottle of 2,000 International Units (IU) vitamin D3 drops (Ddrops®, Ddrops Company). Participants will be instructed to take two drops daily for six months, for a total daily dose of 4,000 IU.
Sliding Hip Screw and Vitamin D placeboVitamin D PlaceboParticipants in the placebo group will receive an identical bottle of placebo drops with no active ingredient. Similarly, they will be instructed to take two drops daily for six months. The placebo supplement is also manufactured by the Ddrops Company.
Sliding Hip Screw and Vitamin D supplementationSliding Hip ScrewParticipants allocated to the vitamin D Group will be given a six-month supply of vitamin D3 supplementation. Participants in the vitamin D Group will receive a bottle of 2,000 International Units (IU) vitamin D3 drops (Ddrops®, Ddrops Company). Participants will be instructed to take two drops daily for six months, for a total daily dose of 4,000 IU.
Cancellous Screws and Vitamin D placeboCancellous ScrewsParticipants in the placebo group will receive an identical bottle of placebo drops with no active ingredient. Similarly, they will be instructed to take two drops daily for six months. The placebo supplement is also manufactured by the Ddrops Company.
Cancellous Screws and Vitamin D placeboVitamin D PlaceboParticipants in the placebo group will receive an identical bottle of placebo drops with no active ingredient. Similarly, they will be instructed to take two drops daily for six months. The placebo supplement is also manufactured by the Ddrops Company.
Sliding Hip Screw and Vitamin D supplementationVitamin DParticipants allocated to the vitamin D Group will be given a six-month supply of vitamin D3 supplementation. Participants in the vitamin D Group will receive a bottle of 2,000 International Units (IU) vitamin D3 drops (Ddrops®, Ddrops Company). Participants will be instructed to take two drops daily for six months, for a total daily dose of 4,000 IU.
Cancellous Screws and Vitamin D supplementationVitamin DParticipants allocated to the vitamin D Group will be given a six-month supply of vitamin D3 supplementation. Participants in the vitamin D Group will receive a bottle of 2,000 International Units (IU) vitamin D3 drops (Ddrops®, Ddrops Company). Participants will be instructed to take two drops daily for six months, for a total daily dose of 4,000 IU.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Patient Important Outcomes12 months post-surgery

A participant met the primary clinical endpoint if they experienced one or more of the four outcomes:

1. Re-operation: any unplanned surgery related to the treatment of the femoral neck fracture;

2. Femoral head osteonecrosis: any evidence of osteonecrosis on any follow-up medical imaging study (i.e., radiographs, magnetic resonance imaging (MRI), or other advanced imaging study);

3. Severe femoral neck malunion: fracture healing with femoral neck shortening of \>10 mm in any plane on follow-up x-rays; or

4. Nonunion: failure of the fracture to progress towards healing defined as a Radiographic Union Score for Hip (RUSH) score below a pre-determined threshold specific for nonunion at 6 months or greater post-injury.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Non-Operatively-Treated Fracture Healing Complications12 months post-surgery

Fracture healing complications treated non-operatively are presented in this table and included wound healing problems, infection (superficial and deep), hardware failure, hardware breakage, painful hardware, and peri-prosthetic fracture.

Short Form-12 (SF-12) Physical Composite Scale (PCS)Pre-fracture, 6 weeks, 3 months, 6 months, 9 months, 12 months post-surgery

The SF-12 is a 12-item questionnaire that measures self-reported quality of life through an 8-domain profile of functional health and well-being, physical and mental health summary measures and a preference-based health utility index. Scores range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Hip Outcome Score (HOS) Activities of Daily Living ScalePre-fracture, 6 weeks, 3 months, 6 months, 9 months, 12 months post-surgery

The HOS measures self-reported functional status through 28 items and two sub-scales that pertain to activities of daily living (ADLs) or higher level activities such as those necessary to participate in sports. Scores for each subscale range from 0 (least function) to 100 (most function).

Short Form-12 (SF-12) Mental Health Composite Scale (MCS)Pre-fracture, 6 weeks, 3 months, 6 months, 9 months, 12 months post-surgery

The SF-12 is a 12-item questionnaire that measures self-reported quali... If reporting a score on a scale, please include the unabbreviated scale title, the minimum and maximum values, and whether higher scores mean a better or worse outcome. Scores range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Hip Outcome Score (HOS) Sports ScalePre-fracture, 6 weeks, 3 months, 6 months, 9 months, 12 months post-surgery

The HOS measures self-reported functional status through 28 items and two sub-scales that pertain to activities of daily living (ADLs) or higher level activities such as those necessary to participate in sports. Scores for each subscale range from 0 (least function) to 100 (most function).

Radiographic Fracture Healingup to 12 months post-surgery

The date of healing will be determined by the Central Adjudication Committee (CAC). They will consider a fracture as healed when there is obliteration of the fracture line by newly formed bone along the cortices and within the trabecular bone on anterior-posterior and lateral radiographs.

Trial Locations

Locations (20)

Allegheny-Singer Research Institute

🇺🇸

Pittsburgh, Pennsylvania, United States

Inova Health Care Services

🇺🇸

Falls Church, Virginia, United States

St. Michael's Hospital

🇨🇦

Toronto, Ontario, Canada

Ottawa Hospital Research Institute

🇨🇦

Ottawa, Ontario, Canada

Memorial University

🇨🇦

St. John's, Newfoundland and Labrador, Canada

Hamilton Health Sciences

🇨🇦

Hamilton, Ontario, Canada

Kingston General Hospital

🇨🇦

Kingston, Ontario, Canada

Sunnybrook Research Institute

🇨🇦

Toronto, Ontario, Canada

University of California, San Francisco

🇺🇸

San Francisco, California, United States

Indiana University (IU Health Methodist Hospital)

🇺🇸

Indianapolis, Indiana, United States

Hennepin Healthcare System

🇺🇸

Minneapolis, Minnesota, United States

University of Maryland, Baltimore

🇺🇸

Baltimore, Maryland, United States

Royal Columbian Hospital

🇨🇦

New Westminster, British Columbia, Canada

Alfred Health

🇦🇺

Melbourne, Victoria, Australia

Health Sciences Centre Winnipeg

🇨🇦

Winnipeg, Manitoba, Canada

University of British Columbia & Vancouver Costal Health Authority

🇨🇦

Vancouver, British Columbia, Canada

West Virginia University

🇺🇸

Morgantown, West Virginia, United States

The Center for Orthopedic Research and Education (CORE) Institute

🇺🇸

Phoenix, Arizona, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath